| Literature DB >> 32134488 |
Raymund R Razonable1,2, Naoki Inoue3, Swetha G Pinninti4, Suresh B Boppana4,5, Tiziana Lazzarotto6, Liliana Gabrielli6, Giuliana Simonazzi7, Philip E Pellett8, D Scott Schmid9.
Abstract
Human cytomegalovirus (HCMV) infections are among the most common complications arising in transplant patients, elevating the risk of various complications including loss of graft and death. HCMV infections are also responsible for more congenital infections worldwide than any other agent. Congenital HCMV (cCMV) infections are the leading nongenetic cause of sensorineural hearing loss and a source of significant neurological disabilities in children. While there is overlap in the clinical and laboratory approaches to diagnosis of HCMV infections in these settings, the management, follow-up, treatment, and diagnostic strategies differ considerably. As yet, no country has implemented a universal screening program for cCMV. Here, we summarize the issues, limitations, and application of diagnostic strategies for transplant recipients and congenital infection, including examples of screening programs for congenital HCMV that have been implemented at several centers in Japan, Italy, and the United States. Published by Oxford University Press for the Infectious Diseases Society of America 2020.Entities:
Keywords: human cytomegalovirus; congenital infection; diagnosis; pregnancy
Year: 2020 PMID: 32134488 PMCID: PMC7057790 DOI: 10.1093/infdis/jiz601
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226